Background
The prevalence of anomalous origin of the coronary artery from the opposite sinus (ACAOS) is low with around 1% in the general population and has been associated with adverse cardiac events, especially in the young. [1] [2] [3] Based on post mortem studies, ACAOS with an interarterial course (IAC, i.e. a vessel course between the aorta and the pulmonary artery) are associated with an increased risk of sudden cardiac death (SCD). 4 This holds true for both anomalous right cor- like ostium, acute-angle take-off and intramural aortic course are known to confer an increased risk. 5 Coronary computed tomography angiography (CCTA) has been shown to be superior to other imaging modalities in detecting ACAOS, 6 and with its increasing use, particularly in a setting of suspected coronary artery disease (CAD) concerning primarily middle-aged patients with a low-tointermediate cardiovascular risk, higher absolute numbers of individuals with newly and incidentally diagnosed ACAOS are to be expected. However, it remains to be elucidated whether middle-aged patients with uncorrected ACAOS and possible concomitant CAD have a worse outcome compared with a population without coronary artery anomalies. Therefore, we sought to assess the outcome of patients with newly diagnosed ACAOS in the course of CAD evaluation compared with a matched control cohort.
Methods Patient population and follow-up
We performed an observational, matched cohort study with follow-up in a single-centre in Switzerland. We retrospectively identified patients with newly diagnosed ACAOS by CCTA at our institution between March 2003 and May 2015 in patients referred for evaluation of suspected or known CAD. Exclusion criteria were concomitant heart defects and nonSwiss residency (international patients without residency in Switzerland are not part of the outcome registry as they are out of reach for followup integration under Swiss legislation). The control cohort used for matching consisted of a total of 399 consecutive patients who were referred for CAD exclusion at our institution between September 2007 and December 2008, who did not show any coronary artery anomalies and in whom follow-up data was obtained during a previous study to assess the prognostic value of low-dose CCTA with prospective electrocardiogram (ECG) triggering. 7 Exclusion criteria for this cohort were the usual exclusion criteria for CCTA, such as irregular heartbeat, contraindications for b-blocking drugs, failure to reach a heart rate < 65 bpm despite intravenous b-blocking drugs, inability to follow breath-hold commands, known allergy to iodinated contrast agent or renal insufficiency (serum creatinine > 150 lmol/L). Twenty-nine patients (7%) were lost to follow-up in this control cohort. Each ACAOS patient was matched with two controls (i.e. 1:2 matching) from this cohort using the following matching variables: age, gender, history of previous coronary revascularization and segment stenosis score (SSS) as depicted by CCTA. Demographic variables, cardiovascular risk factors and cardiac symptoms at baseline were recorded. Follow-up was performed using telephone interviews with patients and referring physicians. Additionally, electronic medical records were searched for cardiac events. Primary combined endpoint was first major adverse cardiac events (MACE), defined as cardiac death, non-fatal myocardial infarction (MI) or urgent/ non-urgent revascularization by percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). Cardiac death was defined as either sudden death with probable cardiac origin or death caused by acute MI, ventricular arrhythmias or refractory heart failure. Non-fatal MI was defined on the basis of symptoms, ECG and biomarkers of ischaemia. 8 Non-cardiac death was separately analysed in both groups.
CCTA
CCTA was performed on multi-slice CT scanners (LightSpeed VCT XT, Discovery CT 750 HD, and Revolution CT, all GE Healthcare, Waukesha, WI, USA) with prospective ECG triggering according to current guidelines and as previously described in detail. 9, 10 Prior to examination all patients received 2.5 mg isosorbiddinitrate sublingually (Isoket, Schwarz Pharma, Monheim, Germany) and up to 30 mg metoprolol (Beloc Zok, AstraZeneca, London, UK) was administered intravenously if the heart rate per minute was >65 in order to obtain optimal image quality. 10 Iodixanol (Visipaque 320, 320 mg/mL, GE Healthcare) was injected into an antecubital vein followed by 50 mL saline solution. Volume and flow rate were adapted to body surface area. 11 Values for effective radiation dose were estimated for CCTA as the product of the dose length product times a conversion coefficient for the chest (k = 0.014 mSv/(mGy Â cm)).
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Coronary anatomy
ACAOS with a course of the anomalous vessel between the aorta and pulmonary artery or subpulmonary between the aorta and the right ventricular outflow tract were classified as ACAOS with IAC ( Figure 1 ). All ACAOS not matching these criteria were classified as ACAOS without IAC ( Figure 2) . Volume rendered images, virtual angiographic views and double-oblique multi-planar reformatted images were used to identify other high-risk anatomic features such as slit-like vessel origin, acute angle take-off (<45 ), intramural course, elliptical course (defined as height/ width ratio of >1.3) and proximal vessel narrowing of the anomalous vessels (>50% compared with a distal segment of the same vessel) ( Figure 3) . 13, 14 We analysed the extent of atherosclerotic burden using the SSS which reflects the severity of CAD. 15 Each coronary segment was therefore graded based on the extent of luminal diameter narrowing (i.e. score from 0 to 3 with no plaque = 0, <50% stenosis = 1, 50-69% stenosis = 2 and > _ 70% stenosis = 3) as depicted by CCTA. The scores of the 16 coronary segments were summed to yield a total SSS score, ranging from Fisher's exact test and continuous variables by Student's t-test or MannWhitney U-test, as appropriate. We performed Kaplan-Meier event-free survival analysis comparing the time to the first MACE. Event-free survival curves were compared between patients with ACAOS and controls using Kaplan-Meier plots and Cox regression with robust variance estimate, accounting for clustering among matched cases and controls. Hazard ratios (HR) with 95% confidence intervals (CI) are presented. In addition, in a model that incorporates whether the patient was symptomatic as well as the calendar year of diagnosis was performed. A subanalysis was performed between patients with ACAOS with IAC and its control cohort as well as between patients with right-ACAOS and left-ACAOS using the log-rank test. Annual event rates are expressed as the number of patients experiencing MACE as a proportion of the number of patients at risk divided by the number of patient-years follow-up.
Ethics
The study conformed to the principles outlined in the declaration of Helsinki and was evaluated and approved by the local ethics committee (KEK-ZH-Nr. 2015-0235) and written informed consent was obtained from all patients.
Results
Patient population
We identified 68 consecutive patients with ACAOS over the observed period of 12 years. Two (3.0%) patients were lost to follow-up. Thus, 66 (97.0%) patients with ACAOS were included in the final analysis and matched to 132 controls without ACAOS. Patients' and controls' baseline characteristics are presented in Table 1 . Forty (60.6%) patients with ACAOS were identified as having IAC, while 26 (39.4%) did not show IAC. Details on ACAOS characteristics and high-risk anatomic features are depicted in Tables 2 and 3 , respectively. Overall effective radiation dose exposure from CCTA was 1.6 ± 0.7 mSv.
Outcome
Mean overall follow-up was 48.5 ± 33.0 months for the patients in the ACAOS group and 71.3 ± 9.8 (P < 0.001) for the control cohort. During the follow-up period, first MACE occurred in 11 (16.7%) patients in the ACAOS group vs. 31 (23.5%) patients in the control cohort, resulting in an annual event rate of 4.9 and 4.8%, respectively. Cumulative event-free survival as depicted by Kaplan-Meier analysis did not differ significant between groups (log-rank, P = 0.61, Figure 4 ). The HR for ACAOS relative to control was 0.83 with 95% CI (0.43-1.60, P = 0.59). In addition, in a model that incorporates whether the patient was symptomatic as well as the calendar year of diagnosis the HR for ACAOS relative to control was 0.94 (0.39-2.28, P = 0.89). Non-cardiac death occurred in two (3.0%) patients with ACAOS and five (3.5%) in the control cohort. Out of the five patients with ACAOS who underwent non-urgent cardiac surgery, three (4.5%) were ACAOS-related operations (i.e. one patient with reattachment of the anomalous vessel and two patients with CABG of the anomalous vessels). Five (7.6%) underwent non-urgent PCI and 1 (1.5%) patients underwent urgent-PCI of the patients with ACAOS.
Similarly, a sub-analysis of the patients with ACAOS and IAC (40 patients) vs. their controls (80 patients) did not reveal any significant difference regarding MACE in the outcome analysis. During the follow-up period, 7 (17.5%) MACE occurred in patients with ACAOS and IAC vs. 17 (21.3%) in the control cohort resulting in an annual event rate of 5.2% and 4.3%, respectively. Cumulative event-free survival as depicted by Kaplan-Meier analysis did not differ significantly between both groups (log-rank P = 0.97, Figure 5 ), HR 0.98 (95% CI 0.40-2.4, P = 0.97) and HR 1.01 (95% CI 0.39-2.58, P = 0.99) including presence or absence of symptoms in the latter model. A second subanalysis regarding the outcome of patients with right-ACAOS (34 patients) vs. their controls (log-rank, P = 0.57) and left-ACAOS (29 patients) vs. their controls (log-rank, P = 0.57) did not reveal any significant difference in the event-free survival. Among the patients with left-ACAOS and IAC (6 cases) only one underwent non-urgent revascularization of the non-anomalous right coronary artery 1 month after diagnosis. The four patients with syncope at baseline consisted of two male and two female patients, aged 49, 50, 54, and 69 years. Of note, none of them had IAC (one single right coronary artery with retroaortal course, one left main originating from the non-coronary cusp, without a IAC, two circumflex coronary artery originating from the right coronary cusp with retroaortal course) and no MACE occurred in these four patients during follow-up.
Concomitant CAD as depicted by CCTA
In patients with ACAOS, out of a total of 77 anomalous vessels (including multiple anomalous vessels in same patients), 13 (16.9%) vessels showed obstructive CAD. In the same patients, out of the 121 non-anomalous vessels, 24 (19.8%) showed obstructive CAD. Thus, the incidence of obstructive CAD did not differ significantly between anomalous vessel vs. non-anomalous vessels within in the same patients with ACAOS (P = 0.74). Similarly, we found no significant difference (P = 0.07) with regard to the incidence of non-obstructive CAD in anomalous vs. non-anomalous vessels: Nonobstructive coronary artery plaques were found in 45 (11.4%) out of 394 anomalous vessel segments compared with 104 (15.7%) out of 662 non-anomalous vessel segments in the same patients.
Discussion
This is the largest study comparing outcome of middle-aged patients with newly detected ACAOS by CCTA with a matched cohort without ACAOS. Overall outcome of middle-aged patients with ACAOS was favourable and not statistically different to the matched control cohort without coronary artery anomalies. Only a minority (i.e. 4.5%) of patients underwent anomalous vessel related Outcome in middle-aged individuals with ACAOS intervention at follow-up. Of note, no cardiovascular death occurred in our cohort of ACAOS. Furthermore, we found no difference in outcome in patients with ACAOS and IAC vs. ACAOS without IAC or in right-ACAOS vs. left-ACAOS compared with their controls.
Outcome of patients with ACAOS and potential implications on clinical decision making
Patients with ACAOS and especially those with an IAC have received much attention because of the association of these anomalies with SCD. Indeed, ACAOS are one of the most common underlying etiologies of sports-and non-sports related SCD in the young. 5, 16 The increasing use of CCTA worldwide, mainly for CAD exclusion in middle-aged patients with low-to intermediate pretest probability may lead to a further increase of incidental diagnosis of ACAOS. However, whether newly diagnosed ACAOS in middle-aged adults predispose for adverse cardiac events remains controversial. Furthermore, and due to the lack of mid-and long-term outcome data, conclusive guidelines for patient management are not available for this population. Although some evidence exists suggesting that ACAOS in older patients might be less relevant compared with younger patients, the reason remains unclear. 16 The risk conferred by ACAOS is thought to be related directly to the haemodynamic significance of particular anatomic features such as IAC, slit-like ostium, acute angle take-off, intramural course, elliptical vessel course, and proximal vessel narrowing of the anomalous vessel. Patients with these characteristics may therefore be more prone to SCD or MI as a direct consequence of scissor-like shearing, kinking or lateral dynamic compression of the anomalous vessel due to increased pressure in both the aorta and the pulmonary artery during strenuous physical exercise. 14, 17 Although in this study, ACAOS with IAC were significantly more often associated with high-risk anatomical features compared with ACAOS without IAC, outcome did not differ for patients with either variant. This finding may at least in part be explained through the assumption that with increasing age stiffening of the anomalous vessels and the aortic wall occurs which may be protective against dynamic compression of the anomalous vessel. 18 In an older study from Japan with 45 patients and uncorrected ACAOS outcome after 5 years was favourable with a low annual event rate for MACE of only 0.8%. The latter may be explained by the fact that, in contrast to our study, non-urgent revascularization was not part of MACE, single coronary artery anomalies were excluded and concomitant obstructive CAD was underrepresented with only one patient (2.2%) compared with one-third in our study. 19 Clark et al.
reported on the outcome of 22 patients with ACAOS detected by CCTA after a 25-month follow-up where no deaths and only one revascularization due to multi-vessel obstructive CAD were recorded. 20 Another study with 87 patients with only right-ACAOS reported a MI rate of 3.4% after 30 months follow-up. However, patients with concomitant CAD were excluded in this cohort. 21 Similarly, another study assessing patients with ACAOS and IAC revealed no increased short-term risk for SCD. 22 Contrary to our findings, a recent study consisting of 116 patients with ACAOS detected by cardiac magnetic resonance imaging showed an annual event rate of 11.6% for MACE over a median follow-up of 55.2 months. However, children were also included in this study, resulting in a much broader range of age (i.e. 1-85 years) than in our study. The higher rate of MACE was mostly driven by events occurring in the subgroup of patients with ACAOS and IAC, suggesting that IAC might be of more relevance particularly in younger patients. 23 Overall, a noteworthy limitation of the abovementioned literature assessing outcome is the lack of a matched control cohort. In fact, to the best of our knowledge, there is only a single recent study also demonstrating favourable outcome in middle-aged patients with ACAOS compared with controls. 24 However, the study published by
Amato et al. used a smaller sample size and, more importantly, did not match both groups for incidence and severity of CAD as assessed by CCTA. Moreover, the incidence and distribution of CAD in anomalous vs. non-anomalous vessels in the same patients was not assessed.
ACAOS and the role of CAD
The results of some older studies hint at a potential link between ACAOS and its predisposition for CAD in anomalous vessels. 25, 26 However, in this study, we found no evidence for a higher incidence of obstructive or non-obstructive CAD among anomalous vs. nonanomalous coronary arteries. This finding is essentially in line with a study assessing CAD in ACAOS through invasive angiography. 27 Whether older patients with ACAOS are less susceptible for adverse cardiac events or whether the presence of a selection bias towards low-risk patients who survived childhood may have influenced our results remains to be elucidated. Whichever is the case, it may be hypothesized that with ageing, the risk for cardiovascular morbidity and mortality due to ACAOS moves into the background compared with the gradually increasing risk associated with CAD. 28 However, it does not seem that anomalous vessels are per se predisposed for premature CAD compared with non-anomalous vessels. Although recommendations exist regarding surgery in patients with ACAOS, 29 their level of evidence is low and decision making is mostly based on an individual approach. It is obvious that patients and especially young patients with ACAOS, who have symptoms of ischaemia or arrhythmia, are candidates for surgical repair. Albeit in general, surgery in patients with ACOAS has a good short-and longterm outcome 30 recent literature showed similar survival in invasively corrected and uncorrected ACAOS 31, 32 and our findings underline the results that the intrinsic risk of ACAOS, especially in middle-aged patients is far lower than perceived and, thus, support the concept towards a more conservative approach in these patients. Albeit a prospective randomized, case-controlled clinical trial would be the gold standard to evaluate best clinical practice, it is not feasible in this middle-aged population with ACAOS as the end points occur far too rarely. Efforts have been made in establishing a multi-institutional registry, the 'Congenital Heart Surgeons' Society Registry of Anomalous Aortic Origin of a Coronary Artery'. 33 However, as one of the inclusion criteria in the mentioned registry is age under 30 years, we are now strongly encouraging to establish a multi-centre registry, especially in high volume imaging centres, and to include also the middle-aged and older population with ACAOS.
Limitations
It may be perceived as a limitation that we retrospectively included patients referred for CCTA due to suspected CAD. Thus, a selection bias may be present towards a higher pretest probability for CAD.
However, it may be assumed that this would equally affect both the ACAOS as well as the control cohort. The highest-risk group with left-ACAOS, consisted only a few patients, and although there was no statistical difference observed, a type two error cannot be definitely excluded. Finally, any conclusions drawn from this study should be limited to a middle-aged patient population with ACAOS. The sample size was rather small with relatively low confirmatory power because ACAOS is rare. With a HR around one for ACAOS and ACAOS with IAC relative to controls, these data do not support the hypothesis that patients with ACAOS or ACAOS with IAC have poorer prognosis with higher momentary hazard of MACE.
Conclusion
In middle-aged individuals with newly diagnosed ACAOS and possible concomitant CAD, mid-term outcome is favourable and not statistically different to a matched control cohort without coronary artery anomaly, regardless of whether ACAOS with or without IAC variants are present.
